Recurrent respiratory papillomatosis (RRP) is a rare condition characterised by exophytic proliferative lesions (papillomas) in the airway, mainly at the larynx, caused by human papillomavirus (HPV) infection. The symptoms may vary from hoarseness to respiratory distress, and the disease may present a devastating impact on the quality of life of affected patients due to the high number of recurrences, often requiring multiple surgeries, or even tracheostomy. 1 The prevalence of RRP is in decline with the introduction of the HPV vaccine; however, RRP still is the most common benign laryngeal tumour in children. 1